From: Identification of Phospholipid Scramblase 1 as a Biomarker and Determination of Its Prognostic Value for Colorectal Cancer
CRC
No. tested
Sensitivity
CEAa (A)
PLSCR1b(B)
Combined (A) + (B)
Early stage
25
4 (16%)
20 (80%)
Advanced stage
34
18 (53%)
27 (79%)
30 (88%)
All CRC patients
59
22 (37%)
47 (80%)
50 (85%)